> top > docs > PubMed:30651794 > annotations

PubMed:30651794 JSONTXT

Annnotations TAB JSON ListView MergeView

sonoma2

Id Subject Object Predicate Lexical cue
T0 7-11 GENE denotes MEG3
T1 15-28 NEGREG denotes downregulated
T2 32-54 DISEASE denotes ankylosing spondylitis
T3 59-69 REG denotes associated
T4 75-91 MPA denotes disease activity
T5 118-134 MPA denotes disease duration
T6 161-188 GENE denotes maternally expressed gene 3
T7 190-194 GENE denotes MEG3
T8 215-226 REG denotes participate
T9 230-242 DISEASE denotes osteoporosis
T10 250-258 REG denotes features
T11 267-287 CPA denotes pathological changes
T12 297-307 REG denotes associated
T13 313-324 DISEASE denotes spondylosis
T14 369-380 REG denotes involvement
T15 391-395 GENE denotes MEG3
T16 399-421 DISEASE denotes ankylosing spondylitis
T17 483-505 DISEASE denotes ankylosing spondylitis
T18 545-555 MPA denotes expression
T19 559-563 GENE denotes MEG3
T20 585-593 REG denotes detected
T21 668-684 CPA denotes Disease activity
T22 689-698 REG denotes evaluated
T23 716-738 DISEASE denotes Ankylosing Spondylitis
T24 810-832 DISEASE denotes Ankylosing Spondylitis
T25 838-848 REG denotes diagnostic
T26 858-862 GENE denotes MEG3
T27 863-873 MPA denotes expression
T28 878-900 DISEASE denotes ankylosing spondylitis
T29 972-983 REG denotes correlation
T30 992-996 GENE denotes MEG3
T31 997-1007 MPA denotes expression
T32 1012-1028 CPA denotes disease activity
T33 1033-1041 REG denotes assessed
T34 1115-1131 MPA denotes expression level
T35 1135-1139 GENE denotes MEG3
T36 1168-1178 POSREG denotes high-level
T37 1183-1192 NEGREG denotes low-level
T38 1230-1248 CPA denotes re-hospitalization
T39 1290-1298 REG denotes compared
T40 1328-1339 REG denotes differences
T41 1343-1373 CPA denotes clinicopathological parameters
T42 1465-1469 GENE denotes MEG3
T43 1474-1487 NEGREG denotes downregulated
T44 1491-1513 DISEASE denotes ankylosing spondylitis
T45 1576-1580 GENE denotes MEG3
T46 1581-1598 MPA denotes expression levels
T47 1606-1610 REG denotes used
T48 1626-1637 REG denotes distinguish
T49 1638-1660 DISEASE denotes ankylosing spondylitis
T50 1703-1709 MPA denotes levels
T51 1713-1717 GENE denotes MEG3
T52 1727-1737 REG denotes associated
T53 1769-1796 MPA denotes alcohol/tobacco consumption
T54 1810-1820 REG denotes correlated
T55 1826-1842 MPA denotes disease activity
T56 1847-1863 MPA denotes disease duration
T57 1892-1898 POSREG denotes higher
T58 1899-1916 MPA denotes expression levels
T59 1920-1924 GENE denotes MEG3
T60 1931-1938 NEGREG denotes shorter
T61 1939-1959 MPA denotes hospitalization time
T62 1966-1971 NEGREG denotes lower
T63 1972-1990 CPA denotes re-hospitalization
T64 2056-2060 GENE denotes MEG3
T65 2064-2077 NEGREG denotes downregulated
T66 2081-2103 DISEASE denotes ankylosing spondylitis
T67 2120-2130 REG denotes associated
T68 2136-2152 MPA denotes disease activity
T69 2162-2177 CPA denotes hospitalization
T70 2182-2198 MPA denotes disease duration
R34 T26 T25 ThemeOf MEG3,diagnostic
R35 T27 T25 ThemeOf expression,diagnostic
R36 T26 T27 ThemeOf MEG3,expression
R37 T28 T25 ThemeOf ankylosing spondylitis,diagnostic
R38 T28 T27 ThemeOf ankylosing spondylitis,expression
R0 T0 T1 ThemeOf MEG3,downregulated
R1 T2 T1 ThemeOf ankylosing spondylitis,downregulated
R2 T2 T3 ThemeOf ankylosing spondylitis,associated
R3 T4 T3 ThemeOf disease activity,associated
R4 T4 T1 ThemeOf disease activity,downregulated
R5 T5 T1 ThemeOf disease duration,downregulated
R6 T5 T3 ThemeOf disease duration,associated
R7 T6 T8 ThemeOf maternally expressed gene 3,participate
R8 T6 T11 ThemeOf maternally expressed gene 3,pathological changes
R9 T6 T12 ThemeOf maternally expressed gene 3,associated
R10 T7 T8 ThemeOf MEG3,participate
R11 T9 T8 ThemeOf osteoporosis,participate
R12 T9 T10 ThemeOf osteoporosis,features
R13 T9 T11 ThemeOf osteoporosis,pathological changes
R14 T9 T12 ThemeOf osteoporosis,associated
R15 T11 T10 ThemeOf pathological changes,features
R16 T11 T8 ThemeOf pathological changes,participate
R17 T11 T12 ThemeOf pathological changes,associated
R18 T13 T8 ThemeOf spondylosis,participate
R19 T13 T10 ThemeOf spondylosis,features
R20 T13 T11 ThemeOf spondylosis,pathological changes
R21 T13 T12 ThemeOf spondylosis,associated
R22 T15 T14 ThemeOf MEG3,involvement
R23 T16 T14 ThemeOf ankylosing spondylitis,involvement
R24 T17 T18 ThemeOf ankylosing spondylitis,expression
R25 T17 T20 ThemeOf ankylosing spondylitis,detected
R26 T19 T18 ThemeOf MEG3,expression
R27 T18 T20 ThemeOf expression,detected
R28 T19 T20 ThemeOf MEG3,detected
R29 T21 T22 ThemeOf Disease activity,evaluated
R30 T23 T21 ThemeOf Ankylosing Spondylitis,Disease activity
R31 T23 T22 ThemeOf Ankylosing Spondylitis,evaluated
R32 T24 T21 ThemeOf Ankylosing Spondylitis,Disease activity
R33 T24 T22 ThemeOf Ankylosing Spondylitis,evaluated
R39 T31 T29 ThemeOf expression,correlation
R40 T32 T29 ThemeOf disease activity,correlation
R41 T29 T33 ThemeOf correlation,assessed
R42 T30 T29 ThemeOf MEG3,correlation
R43 T30 T31 ThemeOf MEG3,expression
R44 T30 T32 ThemeOf MEG3,disease activity
R45 T30 T33 ThemeOf MEG3,assessed
R46 T32 T31 ThemeOf disease activity,expression
R47 T31 T33 ThemeOf expression,assessed
R48 T32 T33 ThemeOf disease activity,assessed
R49 T35 T34 ThemeOf MEG3,expression level
R50 T34 T36 ThemeOf expression level,high-level
R51 T35 T36 ThemeOf MEG3,high-level
R52 T35 T37 ThemeOf MEG3,low-level
R53 T38 T39 ThemeOf re-hospitalization,compared
R54 T41 T40 ThemeOf clinicopathological parameters,differences
R55 T42 T43 ThemeOf MEG3,downregulated
R56 T44 T43 ThemeOf ankylosing spondylitis,downregulated
R57 T45 T46 ThemeOf MEG3,expression levels
R58 T45 T47 ThemeOf MEG3,used
R59 T45 T48 ThemeOf MEG3,distinguish
R60 T46 T47 ThemeOf expression levels,used
R61 T46 T48 ThemeOf expression levels,distinguish
R62 T48 T47 ThemeOf distinguish,used
R63 T49 T46 ThemeOf ankylosing spondylitis,expression levels
R64 T49 T47 ThemeOf ankylosing spondylitis,used
R65 T49 T48 ThemeOf ankylosing spondylitis,distinguish
R66 T51 T50 ThemeOf MEG3,levels
R67 T50 T52 ThemeOf levels,associated
R68 T51 T52 ThemeOf MEG3,associated
R69 T53 T52 ThemeOf alcohol/tobacco consumption,associated
R70 T53 T54 ThemeOf alcohol/tobacco consumption,correlated
R71 T55 T54 ThemeOf disease activity,correlated
R72 T55 T52 ThemeOf disease activity,associated
R73 T56 T54 ThemeOf disease duration,correlated
R74 T58 T57 ThemeOf expression levels,higher
R75 T57 T60 CauseOf higher,shorter
R76 T57 T62 CauseOf higher,lower
R77 T59 T58 ThemeOf MEG3,expression levels
R78 T60 T58 ThemeOf shorter,expression levels
R79 T59 T57 ThemeOf MEG3,higher
R80 T61 T60 ThemeOf hospitalization time,shorter
R81 T61 T57 ThemeOf hospitalization time,higher
R82 T61 T58 ThemeOf hospitalization time,expression levels
R83 T63 T62 ThemeOf re-hospitalization,lower
R84 T64 T65 ThemeOf MEG3,downregulated
R85 T66 T65 ThemeOf ankylosing spondylitis,downregulated
R86 T66 T67 ThemeOf ankylosing spondylitis,associated
R87 T68 T67 ThemeOf disease activity,associated
R88 T69 T68 ThemeOf hospitalization,disease activity
R89 T69 T65 ThemeOf hospitalization,downregulated
R90 T69 T67 ThemeOf hospitalization,associated
R91 T70 T67 ThemeOf disease duration,associated